Editing Data Dictionary: ZfkD Cancer Registry (Germany)

{| class="wikitable"
! Split !! Explanation
|-
| variables || Elements in the XML scheme that do not branch further and thus contain values
|-
| Belongs to || Overarching element in the XML scheme. For reasons of clarity, however, not all levels are shown in the tree
|-
| OBDS module || Provides the reference to the oncological basic data set (OBDS) or the corresponding diagnosis -specific module
|-
| Cardinality || "Here in ""1 - is listed exactly once"" and ""n - can occur several times"" within the overriding element"
|-
| Optional || "Variables with the ""N"" value are mandatory in the transmission. It is not taken into account here whether the variables each have a form like ""unknown"" or similar. exhibit"
|-
| Value range || A reference to the value area is mentioned if deviating from OBDS
|-
| agreement || Agreements on this context can be found on the website
|-
| annotation || "The data record consists of the elements ""person"", ""tumor"" and ""primary diagnosis"", each of which is present in each individual data set, whereby several tumors can be assigned to one person. In contrast, the elements ""operation"", ""systemic therapy"", ""radiation therapy"" and ""consequential event"" are optionally available in the data set. These elements can also be used several times for the same disease case, which enables also to map complex therapy and illness courses. The actual variables containing the evaluable information (column B) are each assigned to one of these elements (column C)."
|}

{| class="wikitable"
! No !! variable !! Surname !! Belongs to !! OBDS/module !! Cardinality !! Optional !! Value range !! agreement
|-
| 1 || Gender ||  || person || 3.9 || 1 || n ||  || 
|-
| 2 || birth date ||  || person || 3.10 || 1 || n || moon || 
|-
| 3 || Died (vital status) ||  || person || new || 1 || n || Died yes/no || #Vitalstatus
|-
| 4 || Date vital status ||  || person || new || 1 || n || moon || 
|-
| 5 || The cause of death (official basic disorders) n. ICD code ||  || person || 20.3 || 1 || J ||  || #TODESULE
|-
| 6 || The cause of death (official basic disorders) n. ICD edition ||  || person || 20.4 || 1 || J ||  || 
|-
| 7 || Further causes of death n. ICD code ||  || person || new || n || J ||  || 
|-
| 8th || Further causes of death n. ICD version ||  || person || new || n || J ||  || 
|-
| 9 || Diagnostic datum ||  || Primary diagnosis || 5.6 || 1 || n || moon || 
|-
| 10 || Place of residence (district) b. diagnosis ||  || Primary diagnosis || 3.15 || 1 || n || District index (5 digits) || 
|-
| 11 || Diagnosis according to ICD code ||  || Primary diagnosis || 5.1 || 1 || n || four -digit || 
|-
| 12 || Diagnosis according to ICD version ||  || Primary diagnosis || 5.2 || 1 || n ||  || 
|-
| 13 || Localization (ICD-O) code ||  || Primary diagnosis || 5.4 || 1 || n ||  || 
|-
| 14 || Localization (ICD-O) version ||  || Primary diagnosis || 5.5 || 1 || J ||  || 
|-
| 15 || Morphology (ICD-O) code ||  || Primary diagnosis || 6.3 || 1 || n ||  || #Morphology [InlineCard]
|-
| 16 || Morphology (ICD-O) version (or Blue Book) ||  || Primary diagnosis || 6.4 || 1 || J ||  || 
|-
| 17 || Grading ||  || Primary diagnosis || 6.6 || 1 || J ||  || 
|-
| 18 || Number of lymph nodes examined ||  || Primary diagnosis || 6.7 || 1 || J ||  || 
|-
| 19 || Number of affected lymph nodes ||  || Primary diagnosis || 6.8 || 1 || J ||  || 
|-
| 20 || CTNM version ||  || Primary diagnosis || 8.2 || 1 || J ||  || #Tnm- [inlineCard]
|-
| 21 || CTNM-Y symbol ||  || Primary diagnosis || 8.3 || 1 || J ||  || 
|-
| 22 || CTNM-R-icon ||  || Primary diagnosis || 8.4 || 1 || J ||  || 
|-
| 23 || CTNM-A symbol ||  || Primary diagnosis || 8.5 || 1 || J ||  || 
|-
| 24 || CTNM-T ||  || Primary diagnosis || 8.9 || 1 || J ||  || 
|-
| 25 || CTNM-N ||  || Primary diagnosis || 8.11 || 1 || J ||  || 
|-
| 26 || CTNM-M ||  || Primary diagnosis || 8.12 || 1 || J ||  || 
|-
| 27 || CTNM-prefix t ||  || Primary diagnosis || 8.6 || 1 || J ||  || 
|-
| 28 || CTNM-Prefix-N ||  || Primary diagnosis || 8.7 || 1 || J ||  || 
|-
| 29 || CTNM-Prefix-M ||  || Primary diagnosis || 8.8 || 1 || J ||  || 
|-
| 30 || CTNM: M symbol ||  || Primary diagnosis || 8.10 || 1 || J ||  || 
|-
| 31 || CTNM: L-category ||  || Primary diagnosis || 8.13 || 1 || J ||  || 
|-
| 32 || CTNM: V-category ||  || Primary diagnosis || 8.14 || 1 || J ||  || 
|-
| 33 || CTNM: PN category ||  || Primary diagnosis || 8.15 || 1 || J ||  || 
|-
| 34 || CTNM: S category ||  || Primary diagnosis || 8.16 || 1 || J ||  || 
|-
| 35 || C-TNM-Uicc ||  || Primary diagnosis || 8.17 || 1 || J ||  || 
|-
| 36 || PTNM version ||  || Primary diagnosis || 8.2 || 1 || J ||  || 
|-
| 37 || Ptnm-Y symbol ||  || Primary diagnosis || 8.3 || 1 || J ||  || 
|-
| 38 || PTNM-R-icon ||  || Primary diagnosis || 8.4 || 1 || J ||  || 
|-
| 39 || PTNM-A symbol ||  || Primary diagnosis || 8.5 || 1 || J ||  || 
|-
| 40 || PTNM-T ||  || Primary diagnosis || 8.9 || 1 || J ||  || 
|-
| 41 || Ptnm-n ||  || Primary diagnosis || 8.11 || 1 || J ||  || 
|-
| 42 || PTNM-M ||  || Primary diagnosis || 8.12 || 1 || J ||  || 
|-
| 43 || PTNM-Prefix-T ||  || Primary diagnosis || 8.6 || 1 || J ||  || 
|-
| 44 || Ptnm-Prefix-N ||  || Primary diagnosis || 8.7 || 1 || J ||  || 
|-
| 45 || PTNM-Prefix-M ||  || Primary diagnosis || 8.8 || 1 || J ||  || 
|-
| 46 || PTNM: M symbol ||  || Primary diagnosis || 8.10 || 1 || J ||  || 
|-
| 47 || PTNM: L-category ||  || Primary diagnosis || 8.13 || 1 || J ||  || 
|-
| 48 || PTNM: V-category ||  || Primary diagnosis || 8.14 || 1 || J ||  || 
|-
| 49 || PTNM: PN category ||  || Primary diagnosis || 8.15 || 1 || J ||  || 
|-
| 50 || PTNM: S category ||  || Primary diagnosis || 8.16 || 1 || J ||  || 
|-
| 51 || ptnm-uicc ||  || Primary diagnosis || 8.17 || 1 || J ||  || #Uicc- [inlineCard]
|-
| 52 || Mestastases seat ||  || Primary diagnosis || 11.1 || n || J ||  || #Seat-the remote metastasis- (Age-primary diagnostic diagnosis [inlinecard])
|-
| 53 || Further classification: name ||  || Primary diagnosis || 9.2 || n || J ||  || 
|-
| 54 || Further classification: stage (expression) ||  || Primary diagnosis || 9.3 || n || J ||  || 
|-
| 55 || Diagnostic protection ||  || Primary diagnosis || 5.7 || 1 || n || Like OBDS, additionally DCO and unknown || #Diagnosis protection
|-
| 56 || Side locals in paired organs ||  || Primary diagnosis || 5.8 || 1 || J ||  || 
|-
| 57 || Dcn ||  || Primary diagnosis || new || 1 || n || Yes No || #DCN- (Death Certificate Notified)
|-
| 58 || Survival time (distance diagnostic death) ||  || Primary diagnosis || new ||  || J || Number of days || 
|-
| 59 || Tumor size in mm (invasive) ||  || Primary diagnosis || Chest module || 1 || J ||  || 
|-
| 60 || Tumor size in mm (DCIS) ||  || Primary diagnosis || Chest module || 1 || J ||  || 
|-
| 61 || Prate therapeutic menopause status ||  || Primary diagnosis || Chest module || 1 || J ||  || 
|-
| 62 || Hormone receptor status :: estrogen ||  || Primary diagnosis || Chest module || 1 || J ||  || 
|-
| 63 || Hormone receptor status: progesterone ||  || Primary diagnosis || Chest module || 1 || J ||  || 
|-
| 64 || Her2neu status ||  || Primary diagnosis || Chest module || 1 || J ||  || 
|-
| 65 || PSA value ||  || Primary diagnosis || Prostate module || 1 || J ||  || 
|-
| 66 || Date PSA ||  || Primary diagnosis || Prostate module || 1 || J ||  || 
|-
| 67 || Gleason score primary value ||  || Primary diagnosis || Prostate module || 1 || J ||  || 
|-
| 68 || Gleason score of secondary value ||  || Primary diagnosis || Prostate module || 1 || J ||  || 
|-
| 69 || Gleason score overall score ||  || Primary diagnosis || Prostate module || 1 || J ||  || 
|-
| 70 || Gleason score occasion ||  || Primary diagnosis || Prostate module || 1 || J ||  || 
|-
| 71 || Tumor thickness in mm ||  || Primary diagnosis || Melanoma module || 1 || J ||  || 
|-
| 72 || Ulceration ||  || Primary diagnosis || Melanoma module || 1 || J ||  || 
|-
| 73 || LDH ||  || Primary diagnosis || Melanoma module || 1 || J ||  || 
|-
| 74 || Rectum: distance of the tumor underride to the anocutan line ||  || Primary diagnosis || Module Darm || 1 || J ||  || 
|-
| 75 || Mutation K-ras-Onkogen ||  || Primary diagnosis || Module Darm || 1 || J ||  || 
|-
| 76 || Operating date ||  || surgery || 13.2 || 1 || n ||  || 
|-
| 77 || Type of operation according to OPS code ||  || surgery || 13.3 || n || n || Ops || 
|-
| 78 || Type of operation according to OPS version ||  || surgery || 13.4 || 1 || n ||  || 
|-
| 79 || Intention of the operation ||  || surgery || 13.1 || 1 || n ||  || 
|-
| 80 || Local assessment residual status ||  || surgery || 10.1 || 1 || J ||  || #Total assessment residual status (for-surgery [inlineCard])-not-transmitted
|-
| 81 || Distance primary diagnosis to surgery ||  || surgery || recalculated) || 1 || J || Number of days || 
|-
| 82 || Start radiation therapy ||  || radiotherapy || 14.5 || 1 || n ||  || 
|-
| 83 || intention ||  || radiotherapy || 14.1 || 1 || J ||  || 
|-
| 84 || Position for the operation ||  || radiotherapy || 14.2 || 1 || J ||  || 
|-
| 85 || Application type ||  || radiotherapy || 14.7 || 1 || J ||  || #Applications-unspoken-
|-
| 86 || Target area ||  || radiotherapy || 14.3 || 1 || ? ||  || 
|-
| 87 || Page target area ||  || radiotherapy || 14.4 || 1 || ? ||  || 
|-
| 88 || Duration of radiation therapy ||  || radiotherapy || new (calculated from 14.5 and 14.6) || 1 || J ||  || #Permanent ray therapy
|-
| 89 || Distance primary diagnosis until the beginning of radiation therapy ||  || radiotherapy || recalculated) || 1 || J ||  || 
|-
| 90 || Intention of systemic therapy ||  || Systemic therapy || 16.1 || 1 || n ||  || 
|-
| 91 || Position systemic therapy for the operation ||  || Systemic therapy || 16.2 || 1 || n ||  || 
|-
| 92 || Art d. Systemic therapy ||  || Systemic therapy || 16.3 || 1 || n ||  || #Art-Systemische-Therapy- (Oder-Awartenden) therapy
|-
| 93 || substance ||  || Systemic therapy || 16.6 || n || J || Description or ATC code || #Building substance [InlineCard]
|-
| 94 || protocol ||  || Systemic therapy || 16.4 || 1 || J ||  || #Settup protocol [inlineCard]
|-
| 95 || Start systemic therapy ||  || Systemic therapy || 16.5 || 1 || n ||  || 
|-
| 96 || Duration of systemic therapy ||  || Systemic therapy || recalculated) || 1 || J ||  || 
|-
| 97 || Distance primary diagnosis until the beginning of systemic therapy ||  || Systemic therapy || recalculated) || 1 || J ||  || 
|-
| 98 || Date of follow -up event ||  || Consequence event || 17.1 || 1 || n ||  || 
|-
| 99 || TNM version ||  || Consequence event || 8.2 || 1 || J ||  || 
|-
| 100 || TNM-Y symbol ||  || Consequence event || 8.3 || 1 || J ||  || 
|-
| 101 || TNM-R-icon ||  || Consequence event || 8.4 || 1 || J ||  || 
|-
| 102 || TNM-A symbol ||  || Consequence event || 8.5 || 1 || J ||  || 
|-
| 103 || TNM-T ||  || Consequence event || 8.9 || 1 || J ||  || 
|-
| 104 || TNM-N ||  || Consequence event || 8.11 || 1 || J ||  || 
|-
| 105 || TNM-M ||  || Consequence event || 8.12 || 1 || J ||  || 
|-
| 106 || TNM-prefix t ||  || Consequence event || 8.6 || 1 || J ||  || 
|-
| 107 || TNM Prefix-N ||  || Consequence event || 8.7 || 1 || J ||  || 
|-
| 108 || TNM-Prefix-M ||  || Consequence event || 8.8 || 1 || J ||  || 
|-
| 109 || TNM: M symbol ||  || Consequence event || 8.10 || 1 || J ||  || 
|-
| 110 || TNM: L-category ||  || Consequence event || 8.13 || 1 || J ||  || 
|-
| 111 || TNM: V-category ||  || Consequence event || 8.14 || 1 || J ||  || 
|-
| 112 || TNM: PN category ||  || Consequence event || 8.15 || 1 || J ||  || 
|-
| 113 || TNM: S category ||  || Consequence event || 8.16 || 1 || J ||  || 
|-
| 114 || TNM-Uicc ||  || Consequence event || 8.17 || 1 || J ||  || 
|-
| 115 || Further classification: name ||  || Consequence event || 9.2 || 1 || J ||  || 
|-
| 116 || Further classification: stage (expression) ||  || Consequence event || 9.3 || 1 || J ||  || 
|-
| 117 || Total settlement tumor status ||  || Consequence event || 17.2 || 1 || n ||  || 
|-
| 118 || Course of local tumor status ||  || Consequence event || 17.3 || 1 || J ||  || 
|-
| 119 || Course tumor status lymph nodes ||  || Consequence event || 17.4 || 1 || J ||  || 
|-
| 120 || Course tumor status distant metastases ||  || Consequence event || 17.5 || 1 || J ||  || 
|-
| 121 || Mestastases seat ||  || Consequence event || 11.1 || n || J
|}